Sialylated HMO immune function is emerging as a fascinating area of nutritional science, revealing how these unique carbohydrates from human breast milk can help support the body’s defense systems throughout life. While most people associate human milk oligosaccharides (HMOs) with infant nutrition, research now shows that sialylated HMOs—particularly 3′-sialyllactose (3′-SL) and 6′-sialyllactose (6′-SL)—may offer immune-modulating benefits that extend well beyond infancy.
What Are Sialylated HMOs?
Sialylated human milk oligosaccharides are complex sugar molecules naturally found in breast milk, making up approximately 10-30% of all HMOs. These specialized carbohydrates contain sialic acid, a nine-carbon sugar that plays crucial roles in cellular recognition and communication. Unlike simple sugars that provide energy, sialylated HMOs resist digestion in the upper gastrointestinal tract and reach the colon intact, where they exert their beneficial effects on both the microbiome and immune system.
The two primary sialylated HMOs—3′-SL and 6′-SL—differ in how the sialic acid molecule attaches to lactose, creating distinct structural variations that influence their biological activities. Research has shown these compounds interact directly with epithelial cells and immune cells, making them potent modulators of immune function.
The Gut-Immune Connection
Understanding how sialylated HMOs support immune function begins with recognizing that approximately 70-80% of the body’s immune cells reside in the gut. This makes the intestinal environment a critical site for immune regulation and response. Sialylated HMOs help support this gut-immune axis through multiple mechanisms.
When sialylated HMOs reach the colon, they serve as selective nutrients for beneficial bacteria, promoting the growth of microbial populations associated with improved immune function. Studies using adult intestinal models have demonstrated that both 3′-SL and 6′-SL supplementation increases short-chain fatty acids (SCFAs), including propionate and butyrate. These SCFAs serve as energy sources for intestinal cells and help support the integrity of the gut barrier—a critical first line of immune defense.
Immune Modulation Through Cytokine Balance
One of the most significant ways sialylated HMOs support immune function is through their influence on cytokine production. Cytokines are signaling molecules that regulate immune cell growth, differentiation, and activity. The balance between pro-inflammatory cytokines (like TNF-α, IL-1β, and IL-6) and anti-inflammatory cytokines (like IL-10 and IL-12) determines how effectively the body responds to threats while avoiding excessive inflammation.
Research on sialylated oligosaccharides has revealed their ability to help regulate this delicate balance. Studies have shown that 3′-SL can suppress the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 in intestinal cells. This anti-inflammatory effect may help reduce the risk of chronic inflammatory conditions while maintaining the immune system’s ability to respond appropriately to genuine threats.
Animal studies have demonstrated that dietary intervention with sialylated oligosaccharides affects cytokine expression in both serum and immune organs like the spleen. These compounds help promote the expression of both pro-inflammatory and anti-inflammatory factors to appropriate extents, supporting a balanced immune response rather than skewing the system in one direction.
Strengthening the Intestinal Barrier
The gut barrier functions as a selective filter, allowing nutrients to pass while blocking harmful microbes, toxins, and antigens. This protective function depends heavily on tight junction proteins, such as ZO-1 and Occludin, which form seals between intestinal cells. When these proteins are disrupted, it can lead to increased intestinal permeability and trigger inappropriate immune responses.
Emerging evidence demonstrates that 3′-SL helps support the expression and maintenance of these critical tight junction proteins. By reinforcing the gut barrier, sialylated HMOs help maintain mucosal defense and contribute to a more resilient intestinal environment. This barrier support is essential because a healthy gut lining prevents unwanted substances from triggering unnecessary immune activation.
Pathogen Interference
Beyond modulating immune cell function, sialylated HMOs act as decoy receptors that can block the attachment of pathogenic bacteria to intestinal cells. Research has shown that sialylated oligosaccharides can inhibit the adhesion of harmful pathogens like Helicobacter pylori to gastrointestinal epithelial cells and reduce the binding of Escherichia coli to intestinal cell models.
This anti-adhesive mechanism works because many pathogens use sialic acid-containing structures as receptors to attach to host cells. When sialylated HMOs are present, they can bind to these pathogens first, preventing them from adhering to the intestinal lining and reducing the likelihood of infection. This protective function helps support the immune system by reducing pathogenic challenges at their point of entry.
Cellular Immune Support
The immune system relies on various cell types working in coordination. T lymphocytes, particularly CD3+ T cells, are essential for cellular immunity and play critical roles in regulating inflammation and mounting immune responses. Research on sialylated oligosaccharides has shown their potential to support healthy T cell populations.
Studies have demonstrated that certain sialylated compounds can help boost CD3+ T lymphocyte ratios, indicating enhanced cellular immunity. Additionally, research on macrophages—the immune system’s “scavengers” that phagocytose pathogens and cellular debris—has shown that sialylated oligosaccharides may support their phagocytic capacity, helping these cells more effectively clear threats from the body.
Antioxidant Activity and Immune Function
The relationship between antioxidant activity and immune function is well-established. Oxidative stress can impair immune cell function and increase susceptibility to infections. Research has shown that sialylated oligosaccharides possess antioxidant properties that may support immune function indirectly.
Studies have demonstrated that certain sialylated compounds can improve the activities of antioxidant enzymes in serum, including superoxide dismutase (SOD), peroxidase (POD), and alkaline phosphatase (AKP). By supporting the body’s antioxidant defenses, these compounds help maintain an optimal environment for immune cells to function effectively.
Beyond the Gut: Systemic Immune Benefits
While much of the immune-modulating activity of sialylated HMOs occurs in the gut, research suggests their benefits may extend systemically. A small fraction of HMOs is absorbed from the intestine and reaches the systemic circulation, where they can potentially interact with immune cells throughout the body.
Studies have shown that sialylated HMOs can bind to cell surface receptors expressed on various immune cells, not just those in the gut. This suggests they may help modulate immune responses at multiple sites throughout the body, contributing to overall immune system balance and function.
Practical Implications for Adult Health
While sialylated HMOs have been extensively studied in the context of infant health, emerging research supports their potential benefits for adults. The immune system faces ongoing challenges throughout life, from dietary factors and stress to environmental exposures and the natural aging process that can affect immune function.
Supporting the gut-immune axis through nutrition represents a promising strategy for maintaining immune balance. Sialylated HMOs help support this connection through multiple pathways: nourishing beneficial gut bacteria, supporting intestinal barrier integrity, modulating cytokine balance, and providing direct anti-adhesive effects against pathogens.
The safety profile of sialylated HMOs is well-established, supported by their extensive use in infant formulas where they help support infant gut health and immune development. Both 3′-SL and 6′-SL have been recognized as safe by regulatory authorities and are approved for use in food products.
The Science Behind Immune Balance
What makes sialylated HMOs particularly interesting is their ability to help support immune balance rather than simply boosting or suppressing immune function. The immune system requires careful calibration—responsive enough to protect against threats but regulated enough to avoid excessive inflammation or inappropriate responses to harmless substances.
Research suggests that sialylated HMOs help support this balance by influencing multiple aspects of immune function simultaneously. They support beneficial bacteria that produce immune-modulating compounds, reinforce the physical barrier that prevents unwanted immune activation, help regulate cytokine production, and interfere with pathogen attachment. This multi-faceted approach supports the immune system’s natural ability to maintain appropriate responses.
Looking Forward
The field of HMO research continues to evolve, with scientists working to understand the full scope of how these unique carbohydrates influence immune function and overall health. While early research focused on their role in infant development, the emerging evidence for benefits in adults opens new possibilities for supporting immune health throughout life.
Current research is exploring optimal dosages, combinations of different HMO structures, and how individual variations in gut microbiota might influence responses to sialylated HMOs. As our understanding deepens, these functional ingredients may become increasingly important tools for supporting immune health through targeted nutritional strategies.
That’s why products like Siallac® were developed—to bring the immune-supporting potential of sialylated oligosaccharides beyond infancy. By harnessing the science behind these remarkable molecules from human milk, Siallac® offers adults a science-backed approach to supporting their body’s natural defenses and maintaining immune balance throughout life.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
- Simon PM, Goode PL, Mobasseri A, Zopf D. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun. 1997;65(2):750-757. https://doi.org/10.1128/IAI.65.2.750-757.1997
- Gao H, Zeng J, Yang Q, Jia T. Dietary intervention with sialylated lactulose affects the immunomodulatory activities of mice. J Dairy Sci. 2021;104(9):9494-9504. https://doi.org/10.3168/jds.2021-20327
- Natividad JM, Marsaux B, Rodenas CLG, et al. Human milk oligosaccharides and lactose differentially affect infant gut microbiota and intestinal barrier in vitro. Nutrients. 2022;14(12):2546. https://doi.org/10.3390/microorganisms12020252
- Zhu M, Zhang W, Dekyi K, et al. 3′-Sialyllactose supplementation reduces inflammation and protects intestinal barrier via microbiota modulation. J Funct Foods. 2024;116:106215. https://doi.org/10.1016/j.jff.2024.106215
- Triantis V, Bode L, van Neerven RJJ. Immunological effects of human milk oligosaccharides. Front Pediatr. 2018;6:190. https://doi.org/10.3389/fped.2018.00190
- ten Bruggencate SJ, Bovee-Oudenhoven IM, Feitsma AL, van Hoffen E, Schoterman MH. Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides. Nutr Rev. 2014;72(6):377-389. https://doi.org/10.1111/nure.12106
- Ayechu-Muruzabal V, Overbeek SA, Kostadinova AI, et al. Interactions of human milk oligosaccharides with the immune system. Front Immunol. 2024;15:1523829. https://doi.org/10.3389/fimmu.2024.1523829
- Perdijk O, van Baarlen P, Fernandez-Gutierrez MM, et al. Sialyllactose and galactooligosaccharides promote epithelial barrier functioning and distinctly modulate microbiota composition and short chain fatty acid production in vitro. Front Immunol. 2019;10:94. https://doi.org/10.3389/fimmu.2019.00094
- Tarr AJ, Galley JD, Fisher SE, et al. Sialic acid-based probiotic intervention improves the neonatal gut microbiota and immune responses by regulating sialylated milk oligosaccharide synthesis. Gut Microbes. 2024;16(1):2334967. https://doi.org/10.1080/19490976.2024.2334967
- He Y, Liu S, Leone S, Newburg DS. Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine. Mucosal Immunol. 2014;7(6):1326-1339.
- Park EJ, Kim LK, Lee JC, et al. 6′-Sialyllactose alleviates muscle fatigue through reduced blood lactate level after treadmill exercise in mice. Nutrients. 2024;16(17):2957. https://doi.org/10.3390/nu16172957
- Vazquez E, Barranco A, Ramírez M, et al. Effects of a human milk oligosaccharide, 2′-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents. J Nutr Biochem. 2015;26(5):455-465.
- Wiciński M, Sawicka E, Gębalski J, et al. Human milk oligosaccharides: Health benefits, potential applications in infant formulas, and pharmacology. Nutrients. 2020;12(1):266.
- Bode L. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology. 2012;22(9):1147-1162.
- Le Doare K, Holder B, Bassett A, Pannaraj PS. Mother’s milk: A purposeful contribution to the development of the infant microbiota and immunity. Front Immunol. 2018;9:361. https://doi.org/10.3389/fimmu.2018.00361
